AVC - Nursing Case Study

Pathophysiology

• Primary mechanism: Acute Vascular Compromise (AVC) primarily results from a blockage in the blood vessels, often due to atherosclerosis. This leads to reduced blood flow and oxygen supply to vital tissues, causing cellular injury or death.

• Secondary mechanism: Inflammation and oxidative stress play crucial roles, as the initial vascular injury triggers an inflammatory response. This further exacerbates vascular damage and may lead to thrombus formation, worsening the occlusion.

• Key complication: If untreated, prolonged ischemia can result in necrosis of affected tissues, leading to functional impairments and potentially life-threatening conditions such as myocardial infarction or stroke.

Patient Profile

Demographics:

63-year-old male, retired construction worker

History:

• Key past medical history: Hypertension, Type 2 Diabetes, Hyperlipidemia

• Current medications: Lisinopril, Metformin, Atorvastatin, Aspirin

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Sudden weakness on the right side of the body

• Key symptoms: Slurred speech, facial droop on the right side, dizziness, headache, difficulty walking

• Vital signs: Blood pressure 185/110 mmHg, heart rate 98 bpm, respiratory rate 22 breaths per minute, temperature 37.6°C, oxygen saturation 94% on room air

Section 1

As the medical team continues to evaluate the 63-year-old male with an acute vascular compromise, new diagnostic results provide further insights into his condition. A CT scan of the brain confirms the presence of an ischemic stroke in the left middle cerebral artery territory, correlating with his right-sided weakness and facial droop. Laboratory studies reveal elevated blood glucose levels at 210 mg/dL, likely exacerbated by the stress of the acute event, and elevated LDL cholesterol at 160 mg/dL, emphasizing his existing hyperlipidemia. The complete blood count shows a mild leukocytosis, indicative of the systemic inflammatory response to the acute vascular event.

Despite the administration of Aspirin and close monitoring, the patient's clinical status begins to shift. His vital signs indicate a blood pressure of 190/115 mmHg, and his oxygen saturation has decreased to 91% on room air, suggesting potential respiratory compromise. Neurological assessment reveals increased confusion and worsening speech difficulties, raising concerns about cerebral edema or progressive ischemia. These changes prompt the healthcare team to consider the need for further interventions, such as thrombolytic therapy or mechanical thrombectomy, to restore perfusion and mitigate additional neurological deficits.

The unfolding scenario highlights the need for vigilant monitoring and timely decision-making to address the emergent complications. It also underscores the importance of controlling modifiable risk factors to prevent further vascular events. The healthcare team must now weigh the risks and benefits of aggressive interventions against the backdrop of the patient's comorbidities and current clinical status, setting the stage for the next phase of his treatment journey.

Section 2

New Complications

As the healthcare team continues to monitor the patient, new complications arise that further complicate his clinical picture. The patient's oxygen saturation continues to decline, now measuring 88% on room air, prompting the initiation of supplemental oxygen therapy via a nasal cannula. Despite this intervention, the patient exhibits increasing respiratory effort, with audible wheezing and an increased respiratory rate of 28 breaths per minute. This change suggests the possibility of aspiration pneumonia, a common complication in patients with neurological deficits like dysphagia following a stroke. A chest X-ray is promptly ordered, revealing bilateral infiltrates, which support the suspicion of pneumonia.

Concurrently, the patient's blood pressure remains persistently elevated, hovering around 195/120 mmHg despite the administration of antihypertensive medications. The elevated blood pressure not only poses a risk for further vascular damage but also contributes to the concern of increased intracranial pressure, potentially exacerbating cerebral edema. Alongside these developments, the patient's blood glucose levels continue to rise, now at 240 mg/dL, indicating the need for tighter glycemic control to minimize further complications. The healthcare team considers the potential benefits of initiating insulin therapy to manage hyperglycemia aggressively.

These new complications necessitate a re-evaluation of the current treatment strategy. The team deliberates on the need for a possible escalation of care, which may include transferring the patient to a higher level of monitoring, such as an intensive care unit, to manage his respiratory and hemodynamic instability effectively. The potential for additional neurological compromise due to ongoing ischemia remains a pressing concern, and the team explores the feasibility of advanced interventions like mechanical thrombectomy to prevent further deterioration. This decision-making process underscores the importance of integrating clinical reasoning with evolving clinical data to optimize patient outcomes.

Section 3

In light of the patient's deteriorating respiratory status and the suspicion of aspiration pneumonia, the healthcare team swiftly initiates a more aggressive approach to manage the patient's condition. The decision is made to escalate his care to the intensive care unit (ICU) for closer monitoring and advanced respiratory support. Upon transfer, the patient is placed on a high-flow nasal cannula, delivering heated and humidified oxygen to maintain adequate oxygen saturation levels. Despite this intervention, his oxygen saturation fluctuates between 90-92%, and he remains tachypneic with a respiratory rate of 30 breaths per minute. Auscultation reveals coarse crackles throughout the lung fields, further corroborating the diagnosis of pneumonia.

Simultaneously, the patient's hemodynamic status continues to be of concern. Although his blood pressure remains elevated at 190/115 mmHg, the team introduces a continuous intravenous infusion of nicardipine, an antihypertensive medication, to achieve better control and reduce the risk of potential intracranial pressure escalation. Neurological assessments indicate mild but noticeable changes in mental status, with the patient exhibiting increased lethargy and a delayed response to verbal stimuli. This observation raises alarms about possible cerebral edema or ongoing ischemic changes, prompting an urgent repeat CT scan of the brain to evaluate for any significant progression or complications.

The healthcare team diligently monitors the patient's blood glucose levels, initiating a sliding scale insulin regimen to address the hyperglycemia. Over the next few hours, blood glucose levels gradually decrease, stabilizing around 180 mg/dL. Despite these interventions, the patient's overall condition remains precarious, and the team contemplates additional imaging and laboratory tests to further delineate the underlying pathophysiology and guide future treatment decisions. This phase of care underscores the critical need for continuous reassessment and adjustment of the management plan, balancing the complexities of multiple organ systems to prevent further decline and optimize recovery.

Section 4

As the patient remains under close observation in the ICU, a new complication arises. Despite the aggressive management of his respiratory and hemodynamic status, the patient begins to exhibit signs of acute kidney injury (AKI). Laboratory tests reveal that his serum creatinine has risen from a baseline of 1.0 mg/dL to 2.5 mg/dL, and his blood urea nitrogen (BUN) levels have increased from 18 mg/dL to 45 mg/dL. Urine output has decreased significantly to less than 400 mL over the past 24 hours, indicating oliguria. These findings suggest that the patient's renal function is being compromised, potentially due to a combination of factors such as hypoperfusion, nephrotoxic medications, or underlying systemic inflammation related to his pneumonia.

In response to these developments, the healthcare team initiates a series of interventions aimed at preserving renal function. Fluid resuscitation is carefully balanced to avoid exacerbating the patient's respiratory status while ensuring adequate renal perfusion. The team also reviews the patient's medication regimen to identify any nephrotoxic agents that can be modified or discontinued. Additionally, nephrology is consulted to provide specialized input on the management of AKI in the context of the patient's complex presentation.

This new complication underscores the interconnected nature of the patient's condition, where the management of one system can impact others. The healthcare team continues to monitor the patient closely, mindful of the need to anticipate further complications and adjust the treatment plan accordingly. This situation presents a critical opportunity for clinical reasoning, as the team must weigh the risks and benefits of each intervention while striving to stabilize the patient's condition and support recovery across multiple organ systems.

Section 5

As the healthcare team continues to manage the patient's acute kidney injury, a new complication emerges. Overnight, the patient develops altered mental status, characterized by confusion and disorientation. Neurological assessment reveals that the patient is drowsy but arousable, with a Glasgow Coma Scale (GCS) score of 12. Vital signs indicate a blood pressure of 105/65 mmHg, heart rate of 98 beats per minute, respiratory rate of 22 breaths per minute, and an oxygen saturation of 93% on high-flow nasal cannula. Laboratory tests indicate a mild metabolic acidosis, with an arterial blood gas showing a pH of 7.32 and bicarbonate level of 18 mmol/L. Electrolyte imbalances are noted, with a potassium level of 5.8 mmol/L and a sodium level of 130 mmol/L.

In response to these findings, the healthcare team recognizes the potential link between the patient's renal impairment and neurological symptoms. The altered mental status may be attributed to uremic encephalopathy, worsened by the metabolic acidosis and electrolyte disturbances. The team prioritizes correcting these imbalances, initiating treatment with intravenous bicarbonate to address the acidosis and considering cautious administration of diuretics to promote renal excretion of potassium. Continuous renal replacement therapy (CRRT) is also considered as a potential intervention if conservative measures do not yield improvement.

The development of altered mental status requires the team to exercise clinical reasoning to balance the management of the patient's respiratory, renal, and neurological conditions. This situation highlights the complexity of critical care, as interventions in one system can have cascading effects on others. The team must closely monitor the patient, reassessing vital signs, neurological status, and laboratory values to ensure that interventions are effective while anticipating any further complications that may arise. As the patient's condition evolves, the healthcare team remains vigilant, ready to adapt the treatment plan to optimize the patient's recovery trajectory.